Literature DB >> 34213763

Joint modeling of zero-inflated longitudinal proportions and time-to-event data with application to a gut microbiome study.

Jiyuan Hu1, Chan Wang1, Martin J Blaser2, Huilin Li1.   

Abstract

Recent studies have suggested that the temporal dynamics of the human microbiome may have associations with human health and disease. An increasing number of longitudinal microbiome studies, which record time to disease onset, aim to identify candidate microbes as biomarkers for prognosis. Owing to the ultra-skewness and sparsity of microbiome proportion (relative abundance) data, directly applying traditional statistical methods may result in substantial power loss or spurious inferences. We propose a novel joint modeling framework [JointMM], which is comprised of two sub-models: a longitudinal sub-model called zero-inflated scaled-beta generalized linear mixed-effects regression to depict the temporal structure of microbial proportions among subjects; and a survival sub-model to characterize the occurrence of an event and its relationship with the longitudinal microbiome proportions. JointMM is specifically designed to handle the zero-inflated and highly skewed longitudinal microbial proportion data and examine whether the temporal pattern of microbial presence and/or the nonzero microbial proportions are associated with differences in the time to an event. The longitudinal sub-model of JointMM also provides the capacity to investigate how the (time-varying) covariates are related to the temporal microbial presence/absence patterns and/or the changing trend in nonzero proportions. Comprehensive simulations and real data analyses are used to assess the statistical efficiency and interpretability of JointMM.
© 2021 The International Biometric Society.

Entities:  

Keywords:  joint model; longitudinal microbiome study; skewness; survival outcome; zero inflation

Year:  2021        PMID: 34213763      PMCID: PMC8720317          DOI: 10.1111/biom.13515

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  17 in total

1.  Joint modeling longitudinal semi-continuous data and survival, with application to longitudinal medical cost data.

Authors:  Lei Liu
Journal:  Stat Med       Date:  2009-03-15       Impact factor: 2.373

2.  Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus.

Authors:  Ian Ganly; Liying Yang; Rachel A Giese; Yuhan Hao; Carlos W Nossa; Luc G T Morris; Matthew Rosenthal; Jocelyn Migliacci; Dervla Kelly; Wenzhi Tseng; Jiyuan Hu; Huilin Li; Stuart Brown; Zhiheng Pei
Journal:  Int J Cancer       Date:  2019-02-19       Impact factor: 7.396

Review 3.  Microbiome-wide association studies link dynamic microbial consortia to disease.

Authors:  Jack A Gilbert; Robert A Quinn; Justine Debelius; Zhenjiang Z Xu; James Morton; Neha Garg; Janet K Jansson; Pieter C Dorrestein; Rob Knight
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

4.  A two-part mixed-effects model for analyzing longitudinal microbiome compositional data.

Authors:  Eric Z Chen; Hongzhe Li
Journal:  Bioinformatics       Date:  2016-05-14       Impact factor: 6.937

5.  Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice.

Authors:  Alexandra E Livanos; Thomas U Greiner; Pajau Vangay; Wimal Pathmasiri; Delisha Stewart; Susan McRitchie; Huilin Li; Jennifer Chung; Jiho Sohn; Sara Kim; Zhan Gao; Cecily Barber; Joanne Kim; Sandy Ng; Arlin B Rogers; Susan Sumner; Xue-Song Zhang; Ken Cadwell; Dan Knights; Alexander Alekseyenko; Fredrik Bäckhed; Martin J Blaser
Journal:  Nat Microbiol       Date:  2016-08-22       Impact factor: 17.745

6.  Antibiotics in early life alter the murine colonic microbiome and adiposity.

Authors:  Ilseung Cho; Shingo Yamanishi; Laura Cox; Barbara A Methé; Jiri Zavadil; Kelvin Li; Zhan Gao; Douglas Mahana; Kartik Raju; Isabel Teitler; Huilin Li; Alexander V Alekseyenko; Martin J Blaser
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

7.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms.

Authors:  J Gregory Caporaso; Christian L Lauber; William A Walters; Donna Berg-Lyons; James Huntley; Noah Fierer; Sarah M Owens; Jason Betley; Louise Fraser; Markus Bauer; Niall Gormley; Jack A Gilbert; Geoff Smith; Rob Knight
Journal:  ISME J       Date:  2012-03-08       Impact factor: 10.302

Review 8.  Microbiome Datasets Are Compositional: And This Is Not Optional.

Authors:  Gregory B Gloor; Jean M Macklaim; Vera Pawlowsky-Glahn; Juan J Egozcue
Journal:  Front Microbiol       Date:  2017-11-15       Impact factor: 5.640

9.  Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues.

Authors:  Graeme L Hickey; Pete Philipson; Andrea Jorgensen; Ruwanthi Kolamunnage-Dona
Journal:  BMC Med Res Methodol       Date:  2016-09-07       Impact factor: 4.615

10.  The Integrative Human Microbiome Project: dynamic analysis of microbiome-host omics profiles during periods of human health and disease.

Authors: 
Journal:  Cell Host Microbe       Date:  2014-09-10       Impact factor: 31.316

View more
  3 in total

1.  ARZIMM: A Novel Analytic Platform for the Inference of Microbial Interactions and Community Stability from Longitudinal Microbiome Study.

Authors:  Linchen He; Chan Wang; Jiyuan Hu; Zhan Gao; Emilia Falcone; Steven M Holland; Martin J Blaser; Huilin Li
Journal:  Front Genet       Date:  2022-02-25       Impact factor: 4.772

2.  MiRKAT-MC: A Distance-Based Microbiome Kernel Association Test With Multi-Categorical Outcomes.

Authors:  Zhiwen Jiang; Mengyu He; Jun Chen; Ni Zhao; Xiang Zhan
Journal:  Front Genet       Date:  2022-04-01       Impact factor: 4.772

3.  A robust and transformation-free joint model with matching and regularization for metagenomic trajectory and disease onset.

Authors:  Qian Li; Kendra Vehik; Cai Li; Eric Triplett; Luiz Roesch; Yi-Juan Hu; Jeffrey Krischer
Journal:  BMC Genomics       Date:  2022-09-19       Impact factor: 4.547

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.